Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen L Goode

Showing results (141-150 of 315) with videos related to

Pageof 32
Sort By:
Journal of the National Cancer Institute|January 30, 2016
PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic MutationsPaul D P Pharoah, Honglin Song, Ed Dicks, et al.
Nature Communications|January 13, 2026
CD39 polymorphism enables lung thrombosis in sickle cell diseaseTomasz Brzoska, Tomasz W Kaminski, Omika Katoch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 23, 2017
Quantifying the Genetic Correlation between Multiple Cancer TypesSara Lindström, Hilary Finucane, Brendan Bulik-Sullivan, et al.
Nucleic Acids Research|April 29, 2015
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancerJeremy Chien, Hugues Sicotte, Jian-Bing Fan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2025
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression SubtypesLindsay J Collin, Kara L Cushing-Haugen, Kathryn L Terry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 3, 2013
Identification of novel variants in colorectal cancer families by high-throughput exome sequencingMelissa S DeRycke, Shanaka R Gunawardena, Sumit Middha, et al.
Cancer Research|November 30, 2018
Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility LocusMelissa A Buckley, Nicholas T Woods, Jonathan P Tyrer, et al.
Genome Medicine|October 27, 2015
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancerAndrew E Teschendorff, Shih-Han Lee, Allison Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2025
High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer ConsortiumYanhong Liu, Yafang Li, Jinyoung Byun, et al.
Gynecologic Oncology|November 19, 2022
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgeryMinh Tung Phung, Penelope M Webb, Anna DeFazio, et al.
Pageof 32

Showing results (141-150 of 315) with videos related to

Sort By:
Pageof 32
Journal of the National Cancer Institute|January 30, 2016
PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic MutationsPaul D P Pharoah, Honglin Song, Ed Dicks, et al.
Nature Communications|January 13, 2026
CD39 polymorphism enables lung thrombosis in sickle cell diseaseTomasz Brzoska, Tomasz W Kaminski, Omika Katoch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 23, 2017
Quantifying the Genetic Correlation between Multiple Cancer TypesSara Lindström, Hilary Finucane, Brendan Bulik-Sullivan, et al.
Nucleic Acids Research|April 29, 2015
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancerJeremy Chien, Hugues Sicotte, Jian-Bing Fan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2025
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression SubtypesLindsay J Collin, Kara L Cushing-Haugen, Kathryn L Terry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 3, 2013
Identification of novel variants in colorectal cancer families by high-throughput exome sequencingMelissa S DeRycke, Shanaka R Gunawardena, Sumit Middha, et al.
Cancer Research|November 30, 2018
Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility LocusMelissa A Buckley, Nicholas T Woods, Jonathan P Tyrer, et al.
Genome Medicine|October 27, 2015
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancerAndrew E Teschendorff, Shih-Han Lee, Allison Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2025
High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer ConsortiumYanhong Liu, Yafang Li, Jinyoung Byun, et al.
Gynecologic Oncology|November 19, 2022
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgeryMinh Tung Phung, Penelope M Webb, Anna DeFazio, et al.
Pageof 32